Find a Provider

James K. Mangan, MD, PhD

James K. Mangan, MD, PhD Physician

Assistant Professor of Clinical Medicine

Languages spoken:

  • Spanish

Dr. Mangan is a Penn Medicine employed physician.

Clinical Specialties

Specialties:

  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Leukemia
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 2011
  • Internal Medicine, 2008

Conditions & Treatments:

  • acute leukemia
  • Acute Lymphocytic Leukemia in Adults (ALL)
  • Acute Myeloid Leukemia (AML)
  • allogeneic transplant
  • Aplastic Anemia
  • Blood Cancer
  • bone marrow failure
  • bone marrow transplant
  • chronic leukemia
  • Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
  • Chronic Myeloid Leukemia (CML)
  • Leukemia
  • myelodysplasia
  • myelofibrosis
  • myeloproliferative disease
  • Myeloproliferative Neoplams (MPN)

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Temple University School of Medicine
Residency: University of Michigan Medical Center
Fellowship: Hospital of the University of Pennsylvania

Memberships

American Society for Blood and Marrow Transplantation, National American Society of Hematology, National

Affiliation

Dr. Mangan is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Reshef R, Hexner EO, Loren AW, Frey NV, Stadtmauer EA, Luger SM, Mangan JK, Gill SI, Vassilev P, Smith J, Van Deerlin VM, Mick R, and Porter DL: Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced intensity conditioning Biol Blood Marrow Transplant 20 (11): 2014.

Mesa R, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Dubinski DG, Boyle J, and Mascarenhas JO.: Impact of myeloproliferative noeplasms (MPNs) on patients' overall health and productivity: results from the MPN LANDMARK SURVEY in the United States. American Society of Hematology Annual Meeting (3183): 2014.

Mesa R, Miller CB, Thyne M, Mangan J, Goldberger S, Fazal S, Ma X, Wilson W, Dubinski DG, Boyle J, and Mascarenhas JO.: Gaps in perception between patients and physicians regarding symptomatology and treatment attitudes for myeloprolifertive neoplasms: MPN LANDMARK SURVEY. American Society of Hematology Annual Meeting (4827): 2014.

Zebrowski A, Hanlon A, Mangan J, Pinto-Martin J, Luger SM, Loren AW, Hexner EO, Reshef R, Gill SI, Smith J, Stadtmauer EA, Porter D, and Frey NV.: Clofarabine busulfan conditioning improves outcomes in patients with active acute myelogenous leukemia undergoing allogeneic stem cell transplant. American Society of Hematology Annual Meeting (1239): 2014.

Frey NV, Luger S, Mangan J, Zebrowski A, Loren AW, Minderman H, Baird J, Porter DL, Hexner EO, Kumar AJ, Luskin MR, Perl AE, and Carroll M: A Phase I study using single agent birinapant in patients with relapsed myelodysplastic syndrome and acute myelogenous leukemia American Society of Hematology Annual Meeting (3758): 2014.

Reshef R, Huffman AP, Gao A, Sell M, Luskin MR, Luger SM, Loren AW, Hexner EO, Nasta SD, Frey NV, Gill SI, Mangan J, Richman LP, Kambayashi T, Stadtmauer EA, Vonderheide RH, and Porter DL: CD8 cell dose in peripheral blood stem-cell grafts correlates with relapse and survival after reduced intensity conditioning allogeneic stem cell transplantation American Society of Hematology Annual Meeting (1260): 2014.

Academic Contact Info

Perelman Center for Advanced Medicine
34th Street and Civic Center Blvd
2nd Floor, West Pavilion

Philadelphia, PA 19104
Patient appointments: 800-789-PENN (7366)